Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer
AIM: To investigate the expression of vascular endothelial growth factor (VEGF) and calcium-binding protein S100A4 in pancreatic cancer and their relationship to the clinicopathological parameters and prognosis of pancreatic cancer. METHODS: Expression status of VEGF and S100A4 was examined in 62 su...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 14; no. 12; pp. 1931 - 1935 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Department of General Surgery, 6th Affiliated Hospital of Shanghai Jiaotong University,Shanghai 200233,China%Department of Pathology, 6th Affiliated Hospital of Shanghai Jiaotong University,Shanghai 200233,China
28.03.2008
The WJG Press and Baishideng |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | AIM: To investigate the expression of vascular endothelial growth factor (VEGF) and calcium-binding protein S100A4 in pancreatic cancer and their relationship to the clinicopathological parameters and prognosis of pancreatic cancer. METHODS: Expression status of VEGF and S100A4 was examined in 62 surgical specimens of primary pancreatic cancer by immunohistochemistry. Correlation between the expression of VEGF and S100A4 and clinicopathological parameters was analyzed. RESULTS: Thirty-eight of 62 (61.3%) specimens of primary pancreatic cancer were positive for S100A4. Thirty-seven (59.7%) specimens showed positive expression of VEGF. The positive correlation between S100A4 and VEGF expression was significant in cancer tissues (P 〈 0.001). S100A4 expression was significantly correlated with tumor size, TNM stage and poorer prognosis. VEGF expression had a significant correlation with poorer prognosis. The prognosis of 17 S100A4- and VEGF-negative cancer patients was significantly better than that of other patients (P 〈 0.05). Distant metastasis (P = 0.001), S100A4- (P = 0.008) and VEGF-positive expression (P = 0.016) were significantly independent prognostic predictors (P 〈 0.05). CONCLUSION: Over-expression of S100A4 and VEGF plays an important role in the development of pancreatic cancer. Combined examination of the two molecules might be useful in evaluating the outcome of patients with pancreatic cancer. |
---|---|
Bibliography: | Immunohistochemistry Prognosis Pancreatic cancer; Prognosis; S100A4;Vascular endothelial growth factor; Immunohistochemistry 14-1219/R Pancreatic cancer S100A4 Vascular endothelial growth factor R736.7 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Correspondence to: Kai-Xing Ai, Department of General Surgery, 6th Affiliated Hospital of Shanghai Jiaotong University, Shanghai 200233, China. akxing8258@sina.com Telephone: +86-21-64369069 |
ISSN: | 1007-9327 2219-2840 |
DOI: | 10.3748/wjg.14.1931 |